Treatment of Metastatic Colorectal Cancer
- 1 August 2011
- journal article
- review article
- Published by Elsevier in Seminars in Oncology
- Vol. 38 (4), 552-560
- https://doi.org/10.1053/j.seminoncol.2011.05.009
Abstract
No abstract availableKeywords
Funding Information
- Alberta Heritage Foundation for Medical Research
This publication has 62 references indexed in Scilit:
- TGF-β Superfamily Receptors—Targets for Antiangiogenic Therapy?Journal of Oncology, 2010
- Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal CancerNew England Journal of Medicine, 2009
- Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal CancerNew England Journal of Medicine, 2009
- Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-GalactoseNew England Journal of Medicine, 2008
- Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trialThe Lancet, 2008
- Front-line Bevacizumab in combination with Oxaliplatin, Leucovorin and 5-Fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II studyBMC Cancer, 2007
- Neoadjuvant Chemotherapy Before Liver Resection for Patients With Unresectable Liver Metastases From Colorectal CarcinomaJournal of Clinical Oncology, 2005
- Systemic Therapy for Colorectal CancerNew England Journal of Medicine, 2005
- A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal CancerJournal of Clinical Oncology, 2004
- Resection of colorectal liver metastasesWorld Journal of Surgery, 1995